New researchers have said that Glucagon-like peptide-1 receptor agonists also known as GLP-1 receptor agonists or incretin mimetics are agonists of the GLP-1 receptor are used to treat Type II Diabetic patients could be used as a novel new way to lower brain pressure.These medicines also reduce obesity and lower hypertension and also cause no hypoglycemia as seen with sulphonylureas bt may cause pancreatitis or cancer rarely. A traumatic brain injury, hydrocephalus, accumulated water in the brain, as well as stroke can cause growing pressure inside your skull which is a major feature of Idiopathic Intracranial Hypertension (IIH).
IHH causes disabling daily headaches and severely raised pressure around the nerves in the eye.Just 10 minutes of dosing of GLP-1 agonist led to rapid and dramatic reduce brain pressure by around 44 per cent, the researchers said, adding that the effects lasted…
